Medicamen Organics Ltd.
NNSE:MEDIORG25.45
INR
-1.30
(-4.86%)
ISIN
INE0PE401018
Return %
Stock
S&P 500
1Y
-29.89
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Bal Kishan Gupta
- Full Time Employees
- 114
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- 10, Community Center No. 2, Ashok Vihar, Phase-II New Delhi DE India 110052
- IPO Date
- Jun 28, 2024
- Website
- medicamenorganics.com
- Similar Companies
- Business
- Medicamen Organics Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and distribution of generic pharmaceutical dosage forms, including tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders, as well as nutraceuticals and food supplements such as protein powders under brands like Soyagrowth and Nusowin, and Glucovita Bolts for Wipro Enterprises. The company operates two WHO-GMP certified plants in Haridwar, with Plant 1 dedicated to iron and folic acid tablets at a capacity of 9 million tablets per day and Plant 2 handling non-beta lactam tablets, capsules, oral liquids, and ointments; it serves as a contract and third-party manufacturer for government institutions and private clients including Morepen, Anglo French, Elder, Bestochem, Shreya Lifesciences, Win Medicare, Jagsonpal Drugs, and international partners like Mission Pharma and Knoll. Its product portfolio encompasses over 84 items across categories such as antibacterials, anti-diarrheals, antifungals, anti-malarials, anti-diabetics, proton pump inhibitors, antihistamines, antihypertensives, anti-lipidemic drugs, antiparasitics, multivitamins, multiminerals, and non-steroidal anti-inflammatory drugs (NSAIDs). Founded in 1995 and headquartered at 10 Community Centre No. 2, Ashok Vihar Phase-II, New Delhi, India, the company markets its products domestically and exports to African countries including Congo, Benin, Togo, Senegal, Burkina Faso, Mozambique, Burundi, and Kenya, as well as CIS and SAARC nations like Kyrgyzstan, Philippines, and Myanmar, with registrations in 13 countries. In recent developments, Medicamen Organics completed the acquisition of Depot Pharmacy YEGO Ltd. in East Africa on October 8, 2024, to strengthen its regional presence; listed on the National Stock Exchange of India (NSE: MEDIORG) via an initial public offering in June 2024 raising INR 10.54 crores for international product registrations, plant upgrades focused on iron tablet capacity, working capital, and general corporate purposes; and announced a strategic investment and manufacturing collaboration with Medi Hub Organic Ltd. in Nepal in early 2025, involving technology transfer and joint procurement to expand into South Asia and the EU.